Clinical document writing consumes months of critical programme time.
Traditional approaches were not built for the pace clinical-stage biotech demands — resulting in delays to your programme.
Metamorphic AI is the regulatory AI platform for clinical-stage biotech, delivering documents like the CSR within a single day — so your team can focus on what moves the programme forward.
From Pre-Clinical to NDA, Metamorphic AI accelerates at every stage.
Clinical development is document-intensive by design. From the first IND application to the final NDA/MAA submission, your programme generates tens of critical regulatory documents — each requiring precision, consistency, and time your team often does not have.
Whether that is an Investigator's Brochure ahead of Phase 1, Phase 2a and 2b CSRs under EOP2 pressure, or CTD Modules 2.5 and 2.7 for submission, compressing the time from data to document without compromising quality or compliance. Our integrated review process brings your statisticians, safety physicians, and medical monitors alongside other subject matter experts into a structured review workflow where every disagreement is captured, referenced, and resolved with a complete correction record.
Underpinning both is a 21 CFR Part 11 compliant audit trail that seals each document at every stage of the workflow, from document generation through to final approved version, giving your QA and regulatory affairs teams the traceability and tamper-evident record they need for inspection readiness.
The result: documents produced over 90% faster, freeing your team to focus on the science, not the paperwork.
Ready to compress the time from data to document?
Speak to our team about how Metamorphic AI fits into your clinical programme — from Phase 1 through to NDA/MAA submission.